John A. Carter
Impact in
- Hepatology top 10%
- Hepatitis C virus research
-
- Spondyloarthritis Studies and Treatments
Papers in
- Oncology 9
- Bone health and treatments 8
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 6
- Co-authors
- Marc Botteman (20 shared papers)Leslie Amass (5 shared papers)Markay Hopps (5 shared papers)Márcia Waddington‐Cruz (4 shared papers)Hartmut Schmidt (4 shared papers)Shari Fallet (4 shared papers)Michelle Stewart (2 shared papers)Satyin Kaura (4 shared papers)
- Journals
- Journal of Medical Economics (7 papers)Value in Health (3 papers)Amyloid (2 papers)Orphanet Journal of Rare Diseases (2 papers)Health and Quality of Life Outcomes (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
John A. Carter
40 papers receiving 643 citations
Peers
Comparison fields: 5 of 71
- Hepatology 51
- Rheumatology 57
- Oncology 93
- Molecular Biology 226
- Genetics 32
Countries citing papers authored by John A. Carter
This map shows the geographic impact of John A. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Carter more than expected).
Fields of papers citing papers by John A. Carter
This network shows the impact of papers produced by John A. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Carter. The network helps show where John A. Carter may publish in the future.
Co-authors
The 25 scholars most cited alongside John A. Carter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 144 | |
| 2 | 2019 | 42 | |
| 3 | 2023 | 38 | |
| 4 | 2012 | 36 | |
| 5 | 2012 | 36 | |
| 6 | 2012 | 32 | |
| 7 | 2020 | 25 | |
| 8 | 2018 | 23 | |
| 9 | 2022 | 23 | |
| 10 | 2012 | 22 | |
| 11 | 1980 | 22 | |
| 12 | 2018 | 21 | |
| 13 | 2011 | 18 | |
| 14 | 2020 | 15 | |
| 15 | 2012 | 15 | |
| 16 | 2017 | 14 | |
| 17 | 2011 | 12 | |
| 18 | 2012 | 12 | |
| 19 | 2011 | 12 | |
| 20 | 2017 | 12 |
About John A. Carter
John A. Carter is a scholar working on Oncology, Molecular Biology, Epidemiology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 40 papers that have together received 659 indexed citations. Recurring topics across this work include Bone health and treatments (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Management of metastatic bone disease (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Liver Disease and Transplantation (3 papers), Hemoglobinopathies and Related Disorders (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Alzheimer's disease research and treatments (2 papers). The work is most often cited by research in Hepatology (51 citations), Rheumatology (57 citations), Oncology (93 citations), Molecular Biology (226 citations) and Genetics (32 citations). John A. Carter has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Marc Botteman, Leslie Amass, Markay Hopps, Márcia Waddington‐Cruz, Hartmut Schmidt, Shari Fallet, Michelle Stewart, Satyin Kaura, Avijeet Chopra and Sonya J. Snedecor. Their work appears in journals such as Journal of Medical Economics, Value in Health, Amyloid, Orphanet Journal of Rare Diseases and Health and Quality of Life Outcomes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.